Found: 120
Select item for more details and to access through your institution.
Crusted scabies (sarcoptic mange) in four cats due to Sarcoptes scabiei infestation
- Published in:
- Journal of Feline Medicine & Surgery, 2006, v. 8, n. 5, p. 327, doi. 10.1016/j.jfms.2006.05.005
- By:
- Publication type:
- Article
“BIRTHDAY SUIT”, “BIRTHDAY CLOTHES”, AND STERNE.
- Published in:
- Notes & Queries, 1968, v. 15, n. 12, p. 463-a
- By:
- Publication type:
- Article
Clinical correlates and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post‐autologous stem cell transplantation lenalidomide maintenance therapy.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 5, p. E157, doi. 10.1002/ajh.26125
- By:
- Publication type:
- Article
A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 5, p. 467, doi. 10.1002/ajh.24693
- By:
- Publication type:
- Article
Phase II trial of nab-paclitaxel in patients with relapsed or refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 12, p. E504, doi. 10.1002/ajh.24548
- By:
- Publication type:
- Article
Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: Results from a phase 2 trial.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 8, p. 640, doi. 10.1002/ajh.22053
- By:
- Publication type:
- Article
Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 9, p. 664, doi. 10.1002/ajh.21777
- By:
- Publication type:
- Article
HACS1 encodes a novel SH3-SAM adaptor protein differentially expressed in normal and malignant hematopoietic cells.
- Published in:
- Oncogene, 2001, v. 20, n. 38, p. 5373, doi. 10.1038/sj.onc.1204698
- By:
- Publication type:
- Article
Can Prayer and Intentionality Be Researched? Should They Be? COUNTERPOINT: Miracles On Demand; Prayer and the Causation of Healing.
- Published in:
- Alternative Therapies in Health & Medicine, 1997, v. 3, n. 6, p. 92
- By:
- Publication type:
- Article
Signaling Pathways in Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, p. S12
- By:
- Publication type:
- Article
High-Resolution Genomic Analysis in Waldenström's Macroglobulinemia Identifies Disease-Specific and Common Abnormalities with Marginal Zone Lymphomas.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 1, p. 39
- By:
- Publication type:
- Article
Bortezomib in Relapsed or Refractory Waldenström's Macroglobulinemia.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 1, p. 74
- By:
- Publication type:
- Article
Enhanced adaptive immunity in mice lacking the immunoinhibitory adaptor Hacs1.
- Published in:
- FASEB Journal, 2010, v. 24, n. 3, p. 947, doi. 10.1096/fj.09-140806
- By:
- Publication type:
- Article
Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-01890-w
- By:
- Publication type:
- Article
Mouse Monoclonal Antibodies Generated from Full Length Human Cereblon: Detection of Cereblon Protein in Patients with Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 9, p. 1999, doi. 10.3390/ijms18091999
- By:
- Publication type:
- Article
The Evolving God: Charles Darwin on the Naturalness of Religion.
- Published in:
- 2014
- By:
- Publication type:
- Book Review
Neutrophilic myelofibrosis presenting as philadelphia chromosome negative BCR non-rearranged chronic myeloid leukemia.
- Published in:
- American Journal of Hematology, 1990, v. 34, n. 1, p. 59, doi. 10.1002/ajh.2830340113
- By:
- Publication type:
- Article
Evolutionary Developmental Biology.
- Published in:
- 2004
- By:
- Publication type:
- Book Review
Effect of Age on the Safety and Efficacy of Selinexor in Patients with Relapsed Refractory Multiple Myeloma: A Post-hoc Analysis of the STORM Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e117, doi. 10.1016/j.clml.2019.09.195
- By:
- Publication type:
- Article
Synergistic Drug Combinations to Overcome Venetoclax Resistance in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e120, doi. 10.1016/j.clml.2019.09.198
- By:
- Publication type:
- Article
Improvements in Renal Function with Selinexor in Relapsed/Refractory Multiple Myeloma: Post-hoc Analyses from the STORM Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e118, doi. 10.1016/j.clml.2019.09.196
- By:
- Publication type:
- Article
Ex vivo sensitivity to venetoclax is predictive of clinical activity.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e114, doi. 10.1016/j.clml.2019.09.189
- By:
- Publication type:
- Article
The contribution of proteasome subunits to Myeloma cell viability and proteasome inhibitor sensitivity.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e77, doi. 10.1016/j.clml.2019.09.122
- By:
- Publication type:
- Article
Mate pair sequencing outperforms fluorescence in situ hybridization and improves diagnostic yield in the genomic characterization of multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e58, doi. 10.1016/j.clml.2019.09.090
- By:
- Publication type:
- Article
Whole Genome Mate-pair Sequencing of Plasma Cell Neoplasm as a Novel Diagnostic Strategy: A Case of Unrecognized t(2;11) Structural Variation.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Phase 2b Results of the STORM Study: Oral Selinexor plus Low Dose Dexamethasone (Sd) in Patients with Penta-Refractory Myeloma (penta-MM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S249, doi. 10.1016/j.clml.2018.07.149
- By:
- Publication type:
- Article
Treatment With Bortezomib-based Therapy, Followed by Autologous Stem Cell Transplantation, Improves Outcomes in Light Chain Amyloidosis: A Retrospective Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Deep and Durable Responses with Weekly Ixazomib, Lenalidomide, and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma (NDMM): Long-Term Follow-up of Patients Not Undergoing Stem Cell Transplantation (SCT).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S335, doi. 10.1016/j.clml.2017.07.151
- By:
- Publication type:
- Article
Prognostic Validation of SKY92 and Its Combination With ISS in an Independent Cohort of Patients With Multiple Myeloma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Activity of 129 single-agent drugs in 228 phase I and II clinical trials in multiple myeloma.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Lenalidomide Plus Melphalan Without Prednisone for Previously Untreated Older Patients With Multiple Myeloma: A Phase II Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 1, p. 19, doi. 10.1016/j.clml.2012.08.009
- By:
- Publication type:
- Article
An Open-Label Single-Arm Pilot Phase II Study (PX-171-003-A0) of Low-Dose, Single-Agent Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2012, v. 12, n. 5, p. 310, doi. 10.1016/j.clml.2012.08.003
- By:
- Publication type:
- Article
Boronizing protects metals against wear.
- Published in:
- Advanced Materials & Processes, 1997, v. 151, n. 3, p. 23
- By:
- Publication type:
- Article
RU486-inducible retrovirus-mediated caspase-3 overexpression is cytotoxic to bcl-x<sub>l</sub>-expressing myeloma cells in vitro and in vivo
- Published in:
- Molecular Therapy, 2003, v. 8, n. 2, p. 230, doi. 10.1016/S1525-0016(03)00146-1
- By:
- Publication type:
- Article
Bone-Marrow-Derived Macrophages Genetically Modified to Produce IL-10 Reduce Injury in Experimental Glomerulonephritis
- Published in:
- Molecular Therapy, 2002, v. 6, n. 6, p. 710, doi. 10.1006/mthe.2002.0802
- By:
- Publication type:
- Article
Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00851-5
- By:
- Publication type:
- Article
Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00820-y
- By:
- Publication type:
- Article
Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00794-x
- By:
- Publication type:
- Article
Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00851-5
- By:
- Publication type:
- Article
Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00820-y
- By:
- Publication type:
- Article
Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00794-x
- By:
- Publication type:
- Article
Distribution of clonal hematopoiesis of indeterminate potential (CHIP) is not associated with race in patients with plasma cell neoplasms.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Functional validation of TERT and TERC variants of uncertain significance in patients with short telomere syndromes.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 12, p. 1, doi. 10.1038/s41408-019-0255-z
- By:
- Publication type:
- Article
Implementing individualized medicine into the medical practice.
- Published in:
- American Journal of Medical Genetics. Part C: Seminars in Medical Genetics, 2014, v. 166C, n. 1, p. 15, doi. 10.1002/ajmg.c.31387
- By:
- Publication type:
- Article
Plasma exchange when myeloma presents as acute renal failure: a randomized, controlled trial.
- Published in:
- 2005
- By:
- Publication type:
- journal article
D(T) PACE as salvage therapy for aggressive or refractory multiple myeloma.
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 6, p. 802, doi. 10.1111/bjh.12325
- By:
- Publication type:
- Article
Extramedullary myeloma whole genome sequencing reveals novel mutations in Cereblon, proteasome subunit G2 and the glucocorticoid receptor in multi drug resistant disease.
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 5, p. 748, doi. 10.1111/bjh.12291
- By:
- Publication type:
- Article
An open-label, single-arm, phase 2 study of single-agent carfilzomib in patients with relapsed and/or refractory multiple myeloma who have been previously treated with bortezomib.
- Published in:
- British Journal of Haematology, 2012, v. 158, n. 6, p. 739, doi. 10.1111/j.1365-2141.2012.09232.x
- By:
- Publication type:
- Article